GlassScriptPhysician profile
Olivia Carrasquillo
NPI 1669827572
$3,127.01
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $562 · 2022: $2,081 · 2023: $468 · 2024: $16.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $738.01 | 2021-2023 | Trulance, Xifaxan |
| Abbvie INC. | $710.26 | 2021-2023 | |
| Gilead Sciences, INC. | $336.49 | 2021-2022 | |
| Janssen Biotech, INC. | $303.36 | 2022-2023 | Remicade, Stelara, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $204.48 | 2021-2023 | Gattex, Entyvio |
| Redhill Biopharma INC. | $144.00 | 2021-2022 | |
| Boston Scientific Corporation | $138.63 | 2023 | Dreamtome Rx 49, Axios, Spyglass |
| Merck Sharp & Dohme LLC | $86.01 | 2021-2022 | |
| Braintree Laboratories, INC. | $60.58 | 2022-2023 | Sutab |
| Qol Medical, LLC | $59.64 | 2022 | |
| Intercept Pharmaceuticals, INC. | $54.44 | 2022 | |
| Daiichi Sankyo INC. | $51.61 | 2022-2023 | Injectafer |
| Celgene Corporation | $51.53 | 2022 | |
| Ironwood Pharmaceuticals, INC | $51.19 | 2022 | |
| Intra-Sana Laboratories | $24.21 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $22.63 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.62 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $19.80 | 2022 | |
| Genmab U.S., INC. | $16.40 | 2024 | Tivdak |
| Digestive Care, INC. | $16.22 | 2022 | |
| Pfizer INC. | $15.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Carrasquillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.